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Abstract
 
Expulsion of gastrointestinal nematodes is associated with pronounced mucosal mast cell
(MMC) hyperplasia, differentiation, and activation, accompanied by the systemic release of
MMC granule chymases (chymotrypsin-like serine proteases). The 
 
b
 
-chymase mouse mast cell
protease-1 (mMCP-1) is expressed predominantly by intraepithelial MMCs, and levels in the
bloodstream and intestinal lumen are maximal at the time of worm expulsion in parasitized
mice. To address the in vivo
 
 
 
functions of MMC-specific 
 
b
 
-chymases, we have generated trans-
genic mice that lack the mMCP-1 gene. They were backcrossed onto a congenic BALB/c
background to investigate the response to nematode infection. The deletion of the mMCP-1
gene is associated with significantly delayed expulsion of 
 
Trichinella spiralis 
 
and increased depo-
sition of muscle larvae in BALB/c mice despite the presence of normal and sometimes in-
creased numbers of MMCs. Neither worm fecundity nor worm burdens were altered in 
 
Nip-
postrongylus
 
-infected mMCP-1
 
2
 
/
 
2
 
 BALB/c mice. These data demonstrate, for the first time,
that the ablation of an MMC-derived effector molecule compromises the expulsion process.
Key words: mucosal immunity • mast cell hyperplasia • helminth parasite • submucosa • 
 
Nippostrongylus brasiliensis
 
Introduction
 
Mast cells are frequently found at interfaces with the exter-
nal environment, where they participate in a wide array of
immunoregulatory functions, including tissue inflammatory
reactions to pathogens. Mucosal mast cells (MMCs) in the
pulmonary and gastrointestinal tracts are distinct from mast
cells in other tissues in their biochemical and functional
properties and in their content of neutral granule serine
proteases (1–4). Pronounced hyperplasia, differentiation,
and activation of MMCs occurs in the gut during nema-
tode infections (5, 6). In rodents and sheep, this is associ-
ated with the systemic release of MMC granule chymases
(chymotrypsin-like serine proteases) at the time of worm
expulsion (6). The MMC-specific 
 
b
 
-chymase rat mast cell
protease-II (rMCP-II) promotes intestinal epithelial perme-
ability by an as yet undefined mechanism that may involve
proteolysis of tight junction proteins (7, 8). It was suggested
that a general function for 
 
b
 
-chymases may be to increase
gut permeability and permit the transfer of antibodies and
other plasma proteins into the niche occupied by the para-
site (7, 8). A homologous 
 
b
 
-chymase, mouse mast cell pro-
tease-1 (mMCP-1), is expressed by MMCs that are pre-
dominantly located within the epithelium (9). mMCP-1 is
expressed constitutively, but levels increase in the blood-
stream and intestinal lumen of parasitized mice and are
maximal at the time of worm expulsion (10). It is possible,
therefore, that rMCP-II, mMCP-1, and sheep mast cell
protease-1, all of which are released systemically and into
the gut lumen (6, 7, 10), participate in the effector response
to intestinal nematodes.
 
To address the in vivo
 
 
 
functions of MMC-specific
 
b
 
-chymases, we have generated transgenic mice that lack
the mMCP-1 gene (11). Preliminary experiments where
mMCP-1
 
2
 
/
 
2
 
 mice were infected with the intestinal nema-
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tode 
 
Nippostrongylus brasiliensis
 
 resulted in altered MMC
hyperplasia compared with infected mMCP-1
 
1
 
/
 
1 
 
controls,
although it was not clear whether these differences were
due to deletion of mMCP-1 or to the different immuno-
logical backgrounds of the two groups of mice (11). We
have now backcrossed the mMCP-1
 
2
 
/
 
2
 
 and mMCP-1
 
1
 
/
 
1
 
mice for 7–10 generations onto a BALB/c background, a
strain in which the kinetics of expulsion of 
 
N. brasiliensis
 
and other intestinal nematodes have been extensively de-
scribed. While rejection of 
 
N. brasiliensis
 
 appears to be
through mast cell independent mechanisms (12), there is
clear evidence that mast cells are central to the expulsion of
 
Trichinella spiralis 
 
(13, 14). Here we investigate the kinetics
of expulsion of both 
 
N. brasiliensis 
 
and
 
 T. spiralis 
 
and the
accompanying MMC hyperplasia in congenic BALB/c
mMCP-1
 
2
 
/
 
2
 
 and mMCP-1
 
1
 
/
 
1
 
 mice.
 
Materials and Methods
 
Transgenic Mice.
 
The generation of mMCP-1
 
2
 
/
 
2
 
 transgenic
mice has been described (11). mMCP-1
 
1
 
/
 
2
 
 mice were back-
crossed from their original MF-1/129/C57BL/6 mixed back-
ground onto a BALB/c background for 10 generations and used
to generate congenic mMCP-1
 
2
 
/
 
2
 
 and mMCP-1
 
1
 
/
 
1
 
 BALB/c
F
 
10 
 
lines. All experiments were done in accordance with the Ani-
mals (Scientific Procedures) Act, 1986.
 
Parasite Infections.
 
To assess responses to intestinal nematode
infection, groups of age- and sex-matched (50:50 males/females
per group) mMCP-1
 
2
 
/
 
2
 
 and mMCP-1
 
1
 
/
 
1
 
 8–12-wk-old BALB/c
F
 
7
 
 or BALB/c F
 
10
 
 mice were infected with either 
 
N. brasiliensis
 
 or
 
T. spiralis
 
 (see below) and killed by halothane inhalation at spe-
cific intervals after infection. Samples of jejunum were removed
starting 10 cm from the pylorus for ELISAs (1 cm), histology (3
cm), and RNA purification (0.5 cm), respectively, and the re-
mainder of the small intestine was used for adult worm isolation.
Maintenance and recovery of the mouse-adapted strain of 
 
N. bra-
siliensis
 
 (donated by Dr. J. Urban, U.S. Department of Agricul-
ture, Beltsville, MD) has been described previously (11). For pri-
mary infections, mice were inoculated subcutaneously with 500
L3 larvae per mouse. Adult worms for secondary challenge were
isolated from BALB/c mice 7 d after infection by Baerman’s
technique and separated from gut contents by centrifugation at
1,250 
 
g
 
 through 100% Histopac (Sigma-Aldrich) for 5 min. Adult
worms were aspirated from the upper layer and resuspended in
PBS/0.1% agar. Mice were each inoculated with 200 adult
worms by gavage 21 d after infection. Both primary and chal-
lenge infections were monitored daily by fecal egg counts.
Maintenance, infection, and recovery of 
 
T. spiralis
 
 larvae was
based on standard methods (15). Mice were infected by gavage
with 300–500 muscle larvae in 0.2 ml of PBS/0.1% agar freshly
isolated from muscle cysts from 30–90 d infected BALB/c mice.
Challenge infections were with 200–300 larvae 3 wk after infec-
tion. Numbers of encysted muscle larvae 30
 
1
 
 d after infection
were calculated from tissue digests from individual cadavers (five
to six per group) (15). Adult worms were isolated by opening
freshly isolated small intestine longitudinally, transferring to a
1-mm-mesh sieve in 100 ml of HBSS (GIBCO BRL), and incu-
bating for 4 h at 37
 
8
 
C. Migrated worms were aspirated and fixed in
1% paraformaldehyde. Parasites were enumerated from five to six
mice per group per time point, and data were compared using the
nonparametric Mann-Whitney two-tailed test using statistical/
 
graphical software (Microsoft Prism) with a significance level of
 
P
 
 
 
,
 
 0.05.
 
Histochemistry and Immunohistochemistry.
 
For histology, 2–3-cm
lengths of jejunum were rolled, villi outermost using the Swiss
roll technique, and fixed in Carnoy’s before subsequent process-
ing and sectioning (11). Mast cells were detected by staining sec-
tions from Carnoy’s-fixed tissue overnight in 0.5% Toluidine
Blue (Merck) in 0.5 mol/liter HCl, pH 0.5, and counterstaining
for 1 s in 1% eosin solution (Surgipath) as described previously
(11). The distribution of mast cells in the epithelium, lamina pro-
pria, submucosa, and muscularis was compared in equivalent areas
of jejunum from five to six mice per time point. Toluidine Blue–
positive mast cells in the epithelium and lamina propria were
enumerated in 20 villus-crypt units (vcu) (16) and in the submu-
cosa/muscularis regions directly below 20 vcu. Numbers of mast
cells in all regions were calculated and expressed per vcu, and data
were compared using the nonparametric Mann-Whitney test as
above.
 
Quantification of mMCP-1.
 
Concentrations of mMCP-1 in
snap-frozen jejunum (micrograms per gram wet weight) and in
serum (nanograms per milliliter) were assayed using the rat mono-
clonal RF6.1-based ELISA (9) with modifications; affinity-puri-
fied monoclonal RF6.1 (5 
 
m
 
g/ml) was the capture antibody, and
polyclonal sheep anti-mMCP (2 
 
m
 
g/ml) (11) was used for detec-
tion of bound mMCP-1. Bound antibody was visualized using
donkey anti–sheep IgG horseradish peroxidase conjugate (Sigma-
Aldrich) at 1:8,000.
 
Detection of mMCP-1, mMCP-2, and mMCP-5 Transcripts by
Reverse Transcription PCR.
 
0.5-cm samples of jejunum were
transferred into 0.5 ml of RNA-later™ reagent (Ambion, Inc.)
and were stored at 4
 
8
 
C overnight and then at 
 
2
 
20
 
8
 
C until pro-
cessing. Samples were homogenized on ice in 2 ml of Tri-
Reagent™ (Sigma-Aldrich) using a tissue homogenizer, and total
RNA was isolated as described previously (17). Contaminating
DNA was removed by incubating 5 
 
m
 
g of total RNA with 6 U of
DNA-free™ DNase (Ambion, Inc.) in 50-
 
m
 
l volumes of 10 mM
Tris-HCl, pH 7.5, 2.5 mM MgCl
 
2
 
, and 0.1 mM CaCl
 
2
 
 for 1 h at
37
 
8
 
C before inactivation using 0.1 volume DNA-free™ DNase
Inactivation Reagent. 1 
 
m
 
g of RNA was reverse transcribed and
amplified by PCR using gene-specific primers for 
 
mMCP-1
 
,
 
mMCP-2
 
, and 
 
mMCP-5
 
 as previously described (11). Primers for
mouse glyceraldehyde-3-phosphate dehydrogenase (GAPDH),
5
 
9
 
-GAAGGGCTCATGACCACAGTCCATG (5
 
9
 
 primer) and
3
 
9
 
-TGTTGCTGTAGCCGTATTCATTGTC (3
 
9
 
 primer), were
purchased from Stratagene. 1/20th volume cDNA from the re-
verse transcription reaction was amplified for 1 min at 94
 
8
 
C, 2
min at 63
 
8
 
C, and 3 min at 72
 
8
 
C for 16, 20, 24, and 28 thermocy-
cles before stopping the reaction at 
 
2
 
20
 
8
 
C, with equivalent
quantities of non–reverse-transcribed RNA as negative controls.
PCR products were visualized on ethidium bromide–stained
1.2% agarose gels, and images were recorded using a Kodak Digi-
tal Science™ Image Station 440CF and 1D Image Analysis soft-
ware.
 
Results
 
mMCP-1
 
2
 
/
 
2
 
 Mice Show a Reduced Ability to Expel Primary
T. spiralis Infections.
 
The responses of mMCP-1
 
2
 
/
 
2
 
 mice
to primary infections with 
 
T. spiralis
 
 were examined. Mice
in both mMCP-1
 
2
 
/
 
2
 
 and mMCP-1
 
1
 
/
 
1 
 
groups were in-
fected with 500 
 
T. spiralis
 
 larvae, and worm burdens were
assessed 6, 14, and 18 d later (
 
n
 
 
 
5
 
 6). By day 18, mice in 
1851
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both groups had reduced worm burdens, but the numbers
of worms were significantly greater (
 
P
 
 
 
, 
 
0.01, Mann-
Whitney test) in the mMCP-1
 
2
 
/
 
2
 
 mice compared with the
mMCP-1
 
1
 
/
 
1 
 
controls (Fig. 1 A).
The delayed expulsion of 
 
T. spiralis 
 
in the absence of
mMCP-1 was further confirmed in fully congenic BALB/c
F
 
10
 
 mMCP-1
 
2
 
/
 
2
 
 and mMCP-1
 
1
 
/1 mice. In this experi-
ment, the infective dose was reduced from 500 to 300
muscle larvae, and 5 rather than 2 time points were chosen
over the expected expulsion period (days 12–16) (18).
Mice in both groups were infected with 300 T. spiralis
muscle larvae, and worm burdens were assessed 1, 6, 13,
14, 15, and 16 d later (n 5 5–6; Fig. 1 B). The recovery of
worms on days 1 and 6 showed that the larvae established
normally in both groups and that the population remained
stable until days 13 and 14 (Fig. 1 B). However, on days 15
and 16, expulsion was complete in five out of six of the
mMCP-11/1 mice, whereas four of six mMCP-12/2 mice
still carried worm burdens (day 15, P , 0.01; Day 16, P ,
0.05; Fig. 1 B). Similarly, when muscle larval burdens were
assessed 30 d after infection, there were significantly larger
(P  , 0.01) numbers in the mMCP-12/2 than in the
mMCP-11/1 mice (Fig. 1 B), a finding that was confirmed
in two other experiments (data not shown).
mMCP-12/2 Mice Expel Secondary T. spiralis Infections Less
Efficiently. To assess the response to a challenge infection
with T. spiralis, BALB/c F10 mMCP-12/2 and mMCP-11/1
mice were each infected with 300 muscle larvae and were
reinfected with an additional 300 larvae 21 d later. As con-
trols for the challenge infections, age- and sex-matched na-
ive mMCP-12/2 and mMCP-11/1 mice were simulta-
neously infected with 300 larvae from the same preparation.
Worm burdens were assessed 6 d after each infection (Fig. 2
A). mMCP-12/2 and mMCP-11/1 mice immunized by in-
fection 21 d before secondary challenge had reduced worm
burdens compared with the unimmunized controls (Fig. 2
A). There was, however, a significantly larger (P , 0.05)
worm burden in the immunized mMCP-12/2 mice when
compared with the mMCP-11/1 controls (Fig. 2 A).
The Expulsion of N. brasiliensis Occurs Normally in mMCP-
12/2 Mice. Preliminary experiments investigating N. bra-
siliensis infections in MF-1/129/C57BL/6 mMCP-12/2
Figure 1. (A) Mean total worm burdens (log10
[x 1 1] 1 SE) from T. spiralis–infected mMCP-
11/1 (filled bars) and mMCP-1 2/2 (open bars)
BALB/c F7 mice. Representative of two experi-
ments. (B) Mean total worm burdens (log10 [x 1
1] 1 SE) and muscle larvae (day 30) (log10 [x 1 1]
1 SE) from T. spiralis–infected mMCP-11/1 and
mMCP-12/2 BALB/c F10 mice. (C and E) Mast
cell counts (1SE) in the jejunum from mMCP-
11/1 and mMCP-12/2 BALB/c F7 mice are
shown 6, 14, and 18 d after primary infection
with 500 T. spiralis muscle larvae per mouse
(shown in A). The cells are counted per vcu in
the epithelium and lamina propria (B; MMC/
vcu) and in the submucosa (C; SMMC/vcu) un-
derlying each vcu. (D and F) Mast cell counts
(1SE) in the jejunum from mMCP-11/1 and
mMCP-12/2 BALB/c F10 mice 0–30 d after pri-
mary infection with 300 T. spiralis muscle larvae
per mouse (shown in D).1852 Role of Mouse Mast Cell Protease-1 in Nematode Expulsion
mice demonstrated that although worm burdens were sig-
nificantly higher, there were no differences in fecal egg
counts compared with mMCP-11/1 controls (11). As this
initial observation could have been due to immunological
differences as a consequence of genetic variability, the ex-
periment was repeated in BALB/c F10 mMCP-12/2 and
mMCP-11/1 mice. Worm survival was monitored by fecal
egg counts (Fig. 3 A). Mice in these same two groups were
rechallenged by gavage with 200 adult worms 21 d after
the first infection. This route of infection was chosen to
avoid any pulmonary immune response normally triggered
by subcutaneous inoculation with L3. Fecal egg counts
were monitored until 4 d after the second challenge, when
egg counts had declined in the majority of animals (Fig. 3
A). No significant differences between the mMCP-11/1
and mMCP-12/2 fecal egg counts were observed during
primary or secondary challenge infection, confirming the
results of previous studies (11). Worm burdens in the two
groups were assessed 3 d after secondary challenge but were
also not significantly different (mMCP-11/1, mean 5 23.1
[SE 11.6]; mMCP-1 2/2, mean 5 8.0 [SE 3.5]).
Altered MMC Kinetics in Parasitized mMCP-12/2 Mice.
Earlier studies (11) suggested that infection with N. brasil-
iensis induced an augmented MMC response in mMCP-
12/2 mice compared with mMCP-11/1 controls, although
this could have reflected immunological differences between
the two groups. Therefore, we investigated the mast cell
recruitment and distribution in congenic BALB/c mMCP-
12/2 and mMCP-11/1 mice after T. spiralis infection.
The numbers of MMCs and submucosal mast cells (SM-
MCs) recorded in the jejunum 6, 14, and 18 d after pri-
mary infection of BALB/c F7 mMCP-12/2 and mMCP-
11/1 mice with T. spiralis (Fig. 1 A) are shown in Fig. 1, C
and E, respectively. There was a trend toward greater num-
bers of MMCs in the mMCP-12/2 mice on day 18 (Fig. 1
C) and significantly higher numbers of SMMCs on days 14
and 18 after infection (Fig. 1 E). There were significantly
higher numbers of total mast cells (P , 0.05) in the je-
junum of mMCP-12/2 mice than the mMCP-11/1 con-
trols on day 18 after infection.
The numbers of MMCs and SMMCs in the jejunum
were also compared in BALB/c F10 mMCP-12/2 and
mMCP-11/1 mice after primary infection with T. spiralis
(Fig. 1 B) over a wider range of time points (Fig. 1, D and
F). When compared with uninfected controls (day 0), the
numbers of MMCs in infected animals were significantly
increased (P , 0.01–0.05) at all times except day 1 (Fig. 1
D). Hyperplasia of MMCs was maximal during the period
of nematode expulsion (days 14–16). MMCs in mMCP-
12/2 mice were more abundant than in the mMCP-11/1
controls on days 14, 16, and 30, and this was significant on
day 14 of infection (P , 0.01; Fig. 1 D). The percentages
of intraepithelial MMCs decreased during the course of in-
fection but were similar in mMCP-11/1 and mMCP-12/2
Figure 2. (A) Mean worm burdens (log10 [x 1 1] 1 SE) in mMCP-11/1 and mMCP-12/2 BALB/c F10 mice after primary infection on day 0 (18) and
challenge infection on day 21 (28) with 300 T. spiralis muscle larvae per mouse. Data are shown 6 d after an initial primary infection (day 6 [18]), 6 d after
receiving the challenge dose (day 6 [28]), and from an equivalent naive group that received the challenge dose only (day 6 [28 Con]). (B). Mast cell counts
(1SE) in the jejunum from mMCP-11/1 (WTs) and mMCP-12/2 (KOs) BALB/c F10 mice are shown 6 d after challenge infection with T. spiralis
(shown in A). See legend for Fig. 1, C and E. (C and D) Toluidine blue/eosin-stained jejunum from mMCP-11/1 (C) and mMCP-12/2 (D) BALB/c
F10 mice 6 d after challenge with T. spiralis. The reduced intensity of staining of MMCs in the villi in mMCP-12/2 jejunum is in accordance with previ-
ous data (11). Note the abundant mast cells in the submucosa of the mMCP-12/2 jejunum compared with that of mMCP-11/1 jejunum.1853 Knight et al. Brief Definitive Report
mice (Table I). Recruitment of SMMCs was significant
(P , 0.01–0.05) on days 14, 16, and 30 only when com-
pared with uninfected controls (day 0; Fig. 1 F). Interest-
ingly, there were significantly greater numbers of SMMCs
in the jejunum of mMCP-12/2 mice than in the mMCP-
11/1 controls on days 14 (P , 0.01), 16 (P , 0.05), and 30
(P , 0.01) after infection (Fig. 1 F). Overall, there were
significantly more total mast cells in the mMCP-12/2 mice
than in the mMCP-11/1 controls on days 14 (P , 0.01)
and 30 (P , 0.05) after infection.
When mast cell hyperplasia was assessed in the jejunal
mucosa and submucosa after challenge infection with T.
spiralis (day 6 after infection), the numbers of MMCs in
mMCP-11/1 and mMCP-12/2 mice were not significantly
different (Fig. 2 B). However, there was generally a higher
proportion of mast cells in the submucosa in jejunal sec-
tions from the mMCP-12/2 mice (Fig. 2 D) than the
mMCP-11/1 controls (Fig. 2 C). When mast cell hyperpla-
sia was assessed 4 d after challenge infection with N. brasil-
iensis, the numbers of MMCs in mMCP-11/1 and mMCP-
12/2 mice were again not significantly different, while the
numbers of SMMCs were again significantly greater (P ,
0.05) in the transgenics compared with wild-type controls
(Fig. 3 B). The percentage of SMMCs in the jejunum of
mMCP-12/2 mice was significantly higher than mMCP-
11/1 controls in challenge infections with either N. brasil-
iensis or T. spiralis (P , 0.01; Table I). This and the pre-
vious data suggests an accumulation of mast cells in the
submucosa during the phase of worm expulsion in both
primary and challenge infections.
Expression and Systemic Release of mMCP-1 Correlates with
Worm Expulsion. Concentrations of mMCP-1 in the je-
junum and serum taken from both groups of mice during
primary infection and during the expulsion phase of a chal-
lenge infection with T. spiralis were compared (Fig. 4, A
and B). There was no detectable mMCP-1 in any of the
samples from the mMCP-12/2 mice (Fig. 4, A and B).
During primary infection, concentrations of mMCP-1 in
Figure 3. (A) Mean fecal egg
counts (log10 [x 1 1] 1 SE) from
mMCP-11/1 (WTs) and mMCP-
12/2 (KOs) BALB/c F10 mice after
receiving a primary infection on day
0 with 500 N. brasiliensis larvae and
challenge infection by gavage with
200 adult worms on day 21. (B)
Mast cell counts (1SE) in the je-
junum from mMCP-11/1 (WTs)
and mMCP-12/2 (KOs) BALB/c
F10 mice 3 d after challenge infection
with adult N. brasiliensis. See legend
for Fig. 1, C and E.
Table I. Percentage Distribution of Mast Cells in the Jejunum of mMCP-12/2 and mMCP-11/1 Mice
Percentage mast cells
Epithelium Lamina propria Submucosa Muscularis
T. spiralis 18 Day 6 WT 89 (3.5) 5 (2.5) 5 (3.1) 0.2 (0.2)
KO 87 (4.4) 7 (2) 9 (6.3) 0.4 (0.4)
Day 14 WT 80 (2.9) 10 (2.4) 9 (2.6) 0.5 (0.2)
KO 75 (5) 15 (2.9) 9 (2.2) 1.5 (0.4)
Day 30 WT 46 (5) 38 (5) 12 (3.5) 4 (1.5)
KO 37 (1.8) 38 (2.5) 19 (1.1) 6 (0.9)
T. spiralis 28 Day 6 WT 63 (4.2) 27 (2) 7.9 (1.2) 1 (0.2)
KO 52 (2.3) 30 (1.2) 14.5** (1.6) 3 (0.8)*
N. brasiliensis 28 Day 4 WT 74 (6.9) 21 (2.8) 3.7 (1.1) 0.6 (0.5)
KO 70 (5.4) 15 (2.3) 10** (1.3) 4.7** (1)
The percentage of mast cells (+SE) counted in the epithelium, lamina propria, submucosa, and muscularis in the jejunum from mMCP-11/1 (WT)
and mMCP-12/2 (KO) BALB/c F10 mice after nematode infection. Data are shown for 6, 14, and 30 d after primary infection with T. spiralis muscle
larvae (Fig. 1 B), 6 d after secondary challenge infection with T. spiralis (Fig. 2 A), and 3 d after secondary challenge infection with N. brasiliensis
(Fig. 3 A). *P , 0.05 and **P , 0.01, as referred to in text.1854 Role of Mouse Mast Cell Protease-1 in Nematode Expulsion
the jejunum or serum of mMCP-11/1 mice on days 6–30
were all significantly higher (P , 0.01) than levels in un-
infected controls. Fig. 4 A illustrates concentrations of
mMCP-1 in jejunal homogenates, which peaked on day 15
and were 80–100-fold higher than in uninfected mMCP-
11/1 controls. However, concentrations of jejunal mMCP-1
6 d after secondary challenge were no greater than levels
recorded 6 d after primary infection (Fig. 4 A), despite the
increased MMC hyperplasia seen at this stage of challenge
infection (Fig. 2 B). In contrast, levels recorded in the se-
rum were significantly higher (P , 0.01) on day 6 after
challenge than on day 6 after primary infection (Fig. 4 B).
This data suggests that there is increased systemic release of
mMCP-1 after challenge infection with T. spiralis.
Transcripts for mMCP-1, mMCP-2, and mMCP-5 were
compared by reverse transcription PCR in jejunal samples
taken from uninfected mMCP-12/2 and mMCP-11/1
BALB/c F10 mice on day 6 after challenge and on day 6 af-
ter primary infection (Fig. 4 C). No mMCP-1 transcripts
were detected in the jejunum from mMCP-12/2 mice, but
mMCP-2 and mMCP-5 appeared to be upregulated (Fig. 4
C), confirming earlier observations that transcription of
these genes was apparently unaffected by mMCP-1 deletion
(11). However, levels of mMCP-1 transcripts recorded 6 d
after primary infection and 6 d after secondary challenge in
the mMCP-11/1 mice did not appear to be upregulated
when compared with levels of transcription of GAPDH
(Fig. 4 C).
Discussion
Here we show for the first time that the abundant and
highly soluble MMC b-chymase, mMCP-1, is involved in
the immunological expulsion of nematode parasites from
the intestine. Importantly, mMCP-1 appears to be required
for efficient expulsion of T. spiralis primary (Fig. 1, A and
B) and challenge infections (Fig. 2 A), but not for the ex-
pulsion of N. brasiliensis (Fig. 3 A). This is in accordance
with the overwhelming evidence that expulsion of T. spira-
lis is highly dependent on MMCs and on the cytokines that
regulate MMC hyperplasia and survival (13, 14, 18, 19). In
contrast, expulsion of N. brasiliensis appears to be indepen-
dent of mast cells in the mouse (20, 21).
Previous studies using bone marrow restoration of mast
cell–deficient c-kit mutant mice (13) or treatment of mice
with antibodies against c-kit (19) or stem cell factor (14)
provided the strongest evidence for the involvement of
mast cells in the rejection of nematodes. However, the in-
terpretation of all such studies relies on an association be-
tween depletion/restoration of MMC populations and
delayed/restored worm expulsion. Perhaps the most in-
triguing aspect of the current data is that delayed expulsion
of T. spiralis occurred in mMCP-12/2 mice, despite the
observations showing MMC hyperplasia was equivalent or
greater than that in the mMCP-11/1controls. Further-
more, this is the first report showing that the elimination of
a ‘downstream’ effector molecule, uniquely derived from
MMCs, affects the survival of a gut-dwelling nematode. It
is not yet clear, however, whether the increased deposition
of muscle larvae in mMCP-12/2 mice was due to the per-
sistence of the adult worms, increased worm fecundity, or a
combination of these two elements.
The initial establishment and survival of T. spiralis larvae
was comparable in both groups of mice, and only during
the phase of worm loss were there any detectable differ-
ences in worm burdens between the mMCP-12/2 and
Figure 4. (A and B) Concentrations of mMCP-1 in the jejunum
(A) (microgram per gram wet weight) and serum (B) (microgram per
milliliter) from mMCP-11/1 and mMCP-12/2 mice 0–30 d after in-
fection with T. spiralis (shown in Fig. 1 B) and 6 d after challenge
(2nd) (Fig. 2 A), as assessed by mMCP-1–specific ELISA. Note that
mMCP-1 was undetectable in the mMCP-12/2 mice. (C) Tran-
scription of chymase genes mMCP-1, -2, and -5 and the housekeep-
ing gene GAPDH in total jejunal RNA from T. spiralis infected
mMCP-11/1 and mMCP-12/2 BALB/c F10 mice. Total RNA was
extracted from uninfected jejunum (Un) and from jejunum 6 d after
primary (1st) and challenge (2nd) infection with T. spiralis. For each
primer set, tracks are loaded with reverse transcription PCR prod-
ucts from PCR reactions stopped after 16, 20, 24, and 28 thermocy-
cles, plus a negative control (equivalent quantities of non–reverse-
transcribed RNA amplified for 28 thermocycles), respectively.1855 Knight et al. Brief Definitive Report
mMCP-11/1  controls. Extensive backcrossing onto a
BALB/c background virtually eliminates the possibility that
a susceptibility gene cosegregates with the mMCP-12/2
genotype. Furthermore, our data on the transcription of
mMCP-2 and -5 suggest that expression of these chymases
is unaffected in mMCP-12/2 mice (Fig. 4 C). The role of
these other chymases in worm rejection has not been in-
vestigated. In view of their close relationship to each other
on chromosome 14 (22), it is likely that mMCP-2, -4, and
-5 are inherited as a complex from the 129 strain mouse
embryonic stem cells used in the targeting of mMCP-1. As
both mMCP-2 and -5 are apparently expressed normally in
the BALB/c mMCP-12/2 mice, it is unlikely that they in-
fluence the expulsion process.
Recent evidence suggests that during the resolution of
MMC hyperplasia, MMCs in the jejunum migrate laterally
and downwards into the submucosa and are sequestered in
the spleen via the bloodstream (23, 24). The migration of
MMCs from the villi to the crypts and submucosa is ac-
companied by an apparent change in phenotype from
MMC-like to connective tissue mast cell–like (23). There-
fore, the excessive abundance of MMC and the accumula-
tion of SMMCs in the jejunum of mMCP-12/2 mice dur-
ing the later stages of nematode infection suggests a defect
in the resolution of MMC hyperplasia in the absence of
mMCP-1, rather than an increase in initial mast cell re-
cruitment. Furthermore, as 90–95% of MMCs expressing
mMCP-1 are intraepithelial and mMCP-11 cells were ab-
sent from the submucosa (reference 9 and our unpublished
observations), the altered mast cell hyperplasia is likely to
be caused by an inability of mMCP-12/2 cells to migrate
or change phenotype or a downstream effect on other cells
in the mucosa. While we have clearly demonstrated a role
for a MMC b-chymase in nematode expulsion, the mecha-
nisms by which it operates remain to be elucidated.
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